News

Breast Cancer Vaccine Shows Promising Results in Clinical Trials

Breast Cancer Vaccine Shows Promising Results in Clinical Trials

An experimental breast cancer vaccine, developed by the Johns Hopkins Kimmel Cancer Center, is currently being tested in clinical trials. After the vaccine is injected it attracts dendritic cells, which are part of the immune system, to the site of administration. The breast cancer vaccine signals to the dendritic cells that the tumor cells need to be attacked and destroyed. As the only truly integrated provider, Yourway supports clinical trials for experimental drugs and offers end-to-end protection for sensitive drug materials.

Back to Index
Media

Upcoming Event

Clinical Trial Supply Europe

March 11-12, 2020
Madrid, Spain
Booth #54

Media

Articles

Agility and Flexibility in a Company That Provides Both Courier and Clinical Packaging Services